Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials.
about
Vaccination with recombinant aspartic hemoglobinase reduces parasite load and blood loss after hookworm infection in dogsGenome of the human hookworm Necator americanus"Rapid-impact interventions": how a policy of integrated control for Africa's neglected tropical diseases could benefit the poorA novel, helminth-derived immunostimulant enhances human recall responses to hepatitis C virus and tetanus toxoid and is dependent on CD56+ cells for its actionX-ray structures of Na-GST-1 and Na-GST-2 two glutathione s-transferase from the human hookworm Necator americanusStructure of a two-CAP-domain protein from the human hookworm parasiteNecator americanusSchistosoma mansonivenom allergen-like protein 4 (SmVAL4) is a novel lipid-binding SCP/TAPS protein that lacks the prototypical CAP motifsMassively parallel sequencing and analysis of the Necator americanus transcriptomeEffect of heterogeneous mixing and vaccination on the dynamics of anthelmintic resistance: a nested modelThe adjuvanticity of an O. volvulus-derived rOv-ASP-1 protein in mice using sequential vaccinations and in non-human primatesVaccines to combat the neglected tropical diseases.Schistosoma mansoni Stomatin like protein-2 is located in the tegument and induces partial protection against challenge infection.Survey of transcripts expressed by the invasive juvenile stage of the liver fluke Fasciola hepaticaMolecular cloning, biochemical characterization, and partial protective immunity of the heme-binding glutathione S-transferases from the human hookworm Necator americanus.Schistosoma mansoni venom allergen like proteins present differential allergic responses in a murine model of airway inflammation.Model for product development of vaccines against neglected tropical diseases: a vaccine against human hookworm.Vaccines: all things considered.A history of hookworm vaccine development.The genomic basis of parasitism in the Strongyloides clade of nematodesThe genome of Strongyloides spp. gives insights into protein families with a putative role in nematode parasitism.Still hope for schistosomiasis vaccineAn ounce of prevention on a budget: a nonprofit approach to developing vaccines against neglected diseases.Identification and Characterization of the Trypanosoma cruzi B-cell Superantigen Tc24Protective immune mechanisms in helminth infectionNecator americanus: the Na-ASP-2 protein secreted by the infective larvae induces neutrophil recruitment in vivo and in vitro.Roadmap to developing a recombinant coronavirus S protein receptor-binding domain vaccine for severe acute respiratory syndromeBrugia pahangi: immunization with early L3 ES alters parasite migration, and reduces microfilaremia and lymphatic lesion formation in gerbils (Meriones unguiculatus)Recombinant subunit vaccines for soil-transmitted helminths.Advances in vaccines against neglected tropical diseases: enhancing physical stability of a recombinant hookworm vaccine through biophysical and formulation studies.Fusion of Na-ASP-2 with human immunoglobulin Fcγ abrogates histamine release from basophils sensitized with anti-Na-ASP-2 IgE.Toxocariasis: America's most common neglected infection of poverty and a helminthiasis of global importance?Onchocerca volvulus: The Road from Basic Biology to a Vaccine.
P2860
Q21563438-7BB03E75-C739-45B1-B61A-8742CEC0AEA0Q22122067-8E45873B-37E5-41D5-A33D-5EEEF7939F3BQ24810845-D2EF0E12-FC44-4232-850E-8F74378A3A29Q27486084-5121F301-E79A-4120-9DA7-A602C0902CD8Q27646442-172F40A3-ED27-4303-994D-0FDD65FE290CQ27667719-92AE6A70-2D63-4E15-872C-BD955D117FBEQ27684904-2BC3DE60-3927-43A5-A520-3BF7175E4974Q28473882-73401EED-5CB0-41FF-9D36-96EE9CF91AE5Q28473967-73144009-C4C1-4AA5-AA8D-93F5350B3F03Q28729899-334471D3-C41F-4F20-9F6E-15E90609D12DQ30425005-D3350265-55A0-49F5-BE19-20BFD7F19E4DQ33531748-E288C438-BF88-4764-8AD5-C014ECDDCA76Q33550595-01407FDA-0795-4692-A2A3-AB0653F2058DQ33769088-FD056616-0318-465E-83CB-2E2BD2C6B86CQ34162984-46F0128A-FCE6-4CC7-91DB-7A2F2E707143Q34893725-48723D3A-893E-49EC-91E4-EC3C86A969A6Q34975057-421E6303-4E04-422B-94D8-05040E74E936Q35881296-00915BE8-1612-4A82-B3C1-1CD36D797EB3Q35909943-9A101F37-81E9-40F9-8B30-444C451A4585Q36130178-62B9AC5B-3DB5-4BEA-BED3-492DC80FB389Q36256373-001B65AA-B43A-48F8-B43C-8A65E5413584Q36445532-1BF3CDFF-00A7-46F5-838C-5902F1275FE4Q36455741-E036161B-C991-4CA1-A89B-E3BDBA910F42Q36481763-A834BF73-5FBE-43A3-805D-9A7E3EFE7172Q36608209-1BF4179C-52E1-4E5D-8AC2-AEBB5EBFBE54Q36650501-EB123EC7-2586-4B74-A555-576F803065DAQ37353605-B912A7DA-4FFA-4EBB-83B8-339C9A19DCD6Q38647737-74384ABF-3080-450F-9CD4-826E77AD77A6Q39360112-6EA35188-6EDE-4A55-B041-1FC81B499CB7Q39624915-0EEEFCC7-BFE4-43FF-820A-ACBEDB144F01Q42577897-432B573C-6083-4498-B3A2-538FC98E8FB0Q46299379-7C27BE3A-8A64-4D6A-A112-BB513430D09F
P2860
Expression of the Necator americanus hookworm larval antigen Na-ASP-2 in Pichia pastoris and purification of the recombinant protein for use in human clinical trials.
description
2005 nî lūn-bûn
@nan
2005 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Expression of the Necator amer ...... use in human clinical trials.
@ast
Expression of the Necator amer ...... use in human clinical trials.
@en
Expression of the Necator amer ...... use in human clinical trials.
@nl
type
label
Expression of the Necator amer ...... use in human clinical trials.
@ast
Expression of the Necator amer ...... use in human clinical trials.
@en
Expression of the Necator amer ...... use in human clinical trials.
@nl
prefLabel
Expression of the Necator amer ...... use in human clinical trials.
@ast
Expression of the Necator amer ...... use in human clinical trials.
@en
Expression of the Necator amer ...... use in human clinical trials.
@nl
P2093
P50
P1433
P1476
Expression of the Necator amer ...... use in human clinical trials.
@en
P2093
Andre Samuel
Gaddam Narsa Goud
Jeffrey M Bethony
Jordan Plieskatt
Lilian Bueno
Maneesha Solanki
Michael Roy
P304
P356
10.1016/J.VACCINE.2005.04.040
P407
P577
2005-09-01T00:00:00Z